Skip to main content

Small Animal Imaging Market Growth Analysis, Opportunities Forecasts Report to 2028

 


Overview

The aim of small animal imaging is to provide advanced multimodal imaging services. Small animal imaging laboratory scientists offer consultation, image analysis, and imaging services. They have state-of-the-art instrumentation for the study of tumors, imaging biomarkers, and high-resolution anatomical imaging in rodent models. The Small Animal Imaging Laboratory also works to develop nanoplatforms for imaging research. The Small Animal Imaging Resource houses state-of-the-art biomedical imaging instruments. Services offered include computed tomography, MRI, PET, bioluminescence, SPECT, ultrasound, and X-ray/CT. These solutions also serve as the primary laboratory for many faculty members involved in the development of imaging technologies. Its expertise spans the fields of preclinical imaging, instrument design, and molecular biology. The core lab provides equipment, expertise, and infrastructure needed for imaging experiments in small animals.

Drivers

Growing demand for non-invasive imaging methods such as PET and MRI to treat domesticated animals is expected to propel the growth of the small animal imaging market throughout the forecast period.

In addition to this, the increasing number of contract research organizations (CROs) to conduct pre-clinical trials on animals is expected to supplement the growth of the small animal imaging market over the forecast period.

Market Dynamics

Increasing focus of market key players in launching new devices for small animal imaging, making investments in R&D as well as on growth strategies such as mergers, collaborations, acquisitions, license and supply agreements, and others are expected to drive growth of the global small animal imaging market over the forecast period (2022-2030).

 

Comments

Popular posts from this blog

The Global Pressure Bandages Market Is Witnessing High Growth Owing To the Increasing Incidence of Surgical Processes in the World

  Market Overview: During a medical emergency, a pressure bandage is used to apply pressure to an area of the body to control bleeding and swelling. There are a variety of types of pressure bandages that can be used for different purposes. The bandage is made up of several parts, including an air bladder, a pad, a closure bar, and an applicator. A pressure bandage can be applied to wounds at any location on the body. This type of dressing is useful in treating various conditions, including gunshot wounds. It can also be used for a temporary holding of a hernia. The bandage is usually vacuum-sealed, so it's easier to carry. Competitive Landscape: Major players operating in the global pressure bandages market include ConvaTec Group PLC., Cardinal Health, 3M, B. Braun Melsungen AG, Lohmann & Rauscher GmbH & Co. KG, Mölnlycke Health Care AB, Smith & Nephew plc., Paul Hartmann AG, and Essity (BSN medical GmbH). Key Market Drivers: Increasing developments by key pla...

Increasing Incidences of Infectious Diseases to Augment the Antibacterial Drugs Market Growth

  Antibacterial drugs are widely used to treat and prevent infectious diseases and are categorized into seven major classes, such as β-Lactams, phenicols, macrolides, quinolones, sulfonamides, tetracyclines, and aminoglycosides, based on their molecular structure. Antibacterial drugs destroy or slow down the growth of bacteria. These medications are also used to treat urinary infections caused by S. aureus, E. coli, Streptococcus pyogenes, and other bacterial infections. They include a range of powerful drugs used to treat diseases caused by bacteria. Antibiotics cannot treat viral infections, such as cold, flu, and most coughs. Antibacterial drugs play a major role in advanced healthcare, as they are widely used to treat infectious diseases, such as tuberculosis, malaria, typhoid, leprosy, hepatitis B, HIV/AIDS, and others. Thus, there is an increasing demand for antibacterial drugs worldwide.  

Fc Protein and Glycoengineered Antibodies Market Is Booming Worldwide 2023-2028

  Global Fc Protein and Glycoengineered Antibodies Market Drivers Key players in the market are focusing on research and development activities and receiving approvals from regulatory bodies, which are expected to boost the global Fc protein and glycoengineered antibodies market growth over the forecast period. For instance, in 2016, Genentech Inc. received approval from the U.S. Food and drug Administration (U.S. FDA) for Tecentriq (Atezolizumab). It is being used for the treatment of urothelial carcinoma. In March 2019, Tecentriq received its second approval from the U.S. FDA for the treatment of small lung cancer. Furthermore, in November 2017, TG Therapeutics, Inc. began its clinical trial of Ublituximab for the treatment of multiple sclerosis. It is currently in third phase of its clinical trial. Factors such as increasing product approvals and robust pipeline are expected to drive the global fc protein and glycoengineered antibodies market growth.  Increasing preva...